Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adoptive immunotherapy

K Ballen1, F M Stewart

  • 1University of Massachusetts Medical Center, Hematology/Oncology Division, Worcester 01655, USA.

Current Opinion in Oncology
|November 25, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group.

Leukemia·2015
Same author

Prostaglandin E2 promotes survival of naive UCB T cells via the Wnt/β-catenin pathway and alters immune reconstitution after UCBT.

Blood cancer journal·2014
Same author

Two locus models of selection and mutation within and among full-sib lines.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
Same author

How to manage the transplant question in myelofibrosis.

Blood cancer journal·2012
Same author

Floating treatment wetlands for domestic wastewater treatment.

Water science and technology : a journal of the International Association on Water Pollution Research·2011
Same author

Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis.

Bone marrow transplantation·2010
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Adoptive immunotherapy leverages the immune system to fight cancer, showing success in treating leukemia and lymphomas post-transplant. Cellular therapy also targets solid tumors like melanoma and lung cancer, with ongoing research to improve safety and efficacy.

Area of Science:

  • Immunology
  • Oncology
  • Cancer Therapy

Background:

  • Significant advancements in cancer treatment involve harnessing the immune system alongside chemotherapy or transplantation.
  • Adoptive immunotherapy has demonstrated efficacy in managing relapsed cancers post-allogeneic bone marrow transplantation.

Purpose of the Study:

  • To summarize the applications and benefits of adoptive immunotherapy and cellular therapy in cancer treatment.
  • To highlight current research directions aimed at mitigating toxicity and refining target tissue selection for these immunotherapies.

Main Methods:

  • Review of existing research on adoptive immunotherapy and cellular therapy in various cancer types.
  • Analysis of treatment outcomes for specific hematologic malignancies and solid tumors.

Related Experiment Videos

Main Results:

  • Adoptive immunotherapy is effective for relapsed chronic myeloid leukemia and Epstein-Barr virus-related lymphomas after allogeneic transplantation.
  • Cellular therapy has shown therapeutic benefits for solid tumors including renal cell carcinoma, melanoma, lung cancer, and breast cancer.

Conclusions:

  • Adoptive immunotherapy and cellular therapy represent powerful strategies in modern cancer treatment.
  • Future research priorities include enhancing the safety profile and optimizing the specificity of these immune-based cancer therapies.